AMPHETAMINE ER 18.8 MG ODT

What it is

AMPHETAMINE ER 18.8 MG ODT is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “amphetamine” and “amphetamine extended-release”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as tablet, orally disintegrating and its route as oral.

Its labelers, the companies named on the label, are Teva Pharmaceuticals, Inc. and Neos Therapeutics, LP.

FDA’s Established Pharmacologic Class for it is Central Nervous System Stimulant.

The NADAC file of 2026-10-14 prices it under 3 NDCs (National Drug Codes); the FDA directory lists 2 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $468.43 for 30 tablets (30 × $15.61431 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

What NADAC measures · Why 30 tablets · NADAC explanation codes

All 3 NDCs

• 00480-3320-19 · not listed as a package in the FDA directory · $15.61431 per EA · eff. 2026-09-23 filed
• 00480-3320-65 · Teva Pharmaceuticals, Inc. · $15.61431 per EA · eff. 2026-09-23 filed
• 62542-0030-30 · Neos Therapeutics, LP · $15.61431 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

18 other products in the NADAC file share an FDA nonproprietary name with AMPHETAMINE ER 18.8 MG ODT.

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 3 NDCs’ NADAC prices is $15.61431 per EA filed.

Of the 203 other products in FDA’s Central Nervous System Stimulant class priced per EA, 23 have a higher middle NADAC price and 180 a lower one. The one in the middle is LISDEXAMFETAMINE 20 MG TB CHEW, at $4.33791 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

We don’t know yet; the card above says why.

Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.